Opportunity Stocks experienced a rather choppy day today, with...

  1. 2,629 Posts.
    lightbulb Created with Sketch. 396
    Opportunity Stocks experienced a rather choppy day today, with returns down due largely to BIT's 15.2% decline, OEC's 8% decline on a joke 200 share worth $60 dump [ you cant get the buyer to buy your shares at a higher price doing this!]  and BC8''s unexpected retreat on buy the rumour sell the fact despite a great resource upgrade announced and of course PNV's yo-yo on the day (see earlier post).

    There were however a few good news notwithstanding the above:
    > AD8 new commercialised video platform launched and already embraced by a US OEM;
    > TNY's reaffirmed guidance of positive cashflow within this calendar year and strong momentum in revenue and subscriber growth saw its sp firmed 12.3% , best performer for the day
    > NST hitting a new all time high of $12.22 [I said it was going to break $12] before closing 1.85% up at $12.11. And with POTUS deliberating weakening the US dollar , I believe we will see gold and gold stocks firming in the months ahead , which is why IMO it would be good to have a few gold counters in the belt as we navigate choppy days and months ahead
    > AMS which I reckon would breach its all time high of $1.45 came pretty close at $1.42 before dropping back to close 2.99% higher at $1.38 , and IMO poised to try again in the next few trading days
    > MVP also hitting all time high of $6,50 today, before afternoon selling drove it down to close almost 1% down at $6.10
    > UUV back to 0.7c , still under $3m stock , but people wanting to hear some news before they take position [ if there is any positive news announcement, it is the usual scramble , a bit like TNY this morning (a bit) ]


    Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7
    0   OPPORTUNITY STOCKS Date stock mentioned in Its Over thread Open price on date stock mentioned 15/7/19 close Change% Potential Upside
    1 1 XRO [XERO] [closed]   11/2/19   $ 46.200   $ 53.600 16.0% Phase 3-4 ; growth & getting in profitability
    2 2 MYE [MASTERMYNE] [closed]   11/2/19   $   0.840   $    0.820 -2.4% Phase 4- growth
    3 3 CLV [CLOVER] [closed]   11/2/19   $   1.525   $    2.130 39.7% Phase 4- growth
    4 4 SFC [SCHAEFFER] [closed]   12/2/19   $ 14.480   $ 14.200 -1.9% Phase 4-growth
    5 5 YOW [YOWIE]   [closed]   19/2/19   $   0.070   $    0.090 28.6% Phase 3-validated; shareholder conflict
    6 6 CAT [CATAPULT]  [closed]   21/2/19   $   0.640   $    0.840 31.3% Phase 3-validated; governance issue
    7 7 PME [PROMEDICUS] [closed]   21/2/19   $   14.45   $    19.95 38.1% Phase 4-growth
    8 8 VHT [VOLPARA]   6/3/19   $   1.147   $    1.660 44.8% Phase 2-3 -validating & ramping
    9 9 NST [NORTHERN STAR]   8/3/19   $ 8.87   $    12.11 36.5% Phase 4- defensive growth
    10 10 ANO [ADVANCED NANOTEK] [closed]   8/3/19   $ 3.05   $ 5.00 63.9% Phase 4-growth
    11 11 CYL [CATALYST METALS]   13/3/19   $ 2.30   $ 2.07 -10.0% Phase 1-positive discovery
    12 12 NUH [NUHEARA] [closed]   13/3/19   $   0.069   $    0.061 -11.6% Phase 1-2 nearing validation; governance issue
    13 13 MWY [MIDWAY]   14/3/19   $   3.980   $    3.500 -12.1% Phase 4- growth
    14 14 D20 [DUXTON WATER]   27/3/19   $   1.530   $    1.450 -5.2% Phase 4-defensive growth & scalability
    15 15 PNV [POLYNOVO]   1/4/19   $   0.760   $    1.580 107.9% Phase 2-3- validated & ramping & getting into profitability
    16 16 DUB [DUBBER]   8/4/19   $   0.925   $    1.310 41.6% Phase 2-3- validated & ramping
    17 17 TTT [TITOMIC]   8/4/19   $   2.300   $    1.940 -15.7% Phase 1-positive discovery
    18 18 EVS [ENVIROSUITE]   10/4/19   $   0.170   $    0.125 -26.5% Phase 2-3- validated & ramping
    19 19 AD8 [AUDINATE]   10/4/19   $   6.290   $    7.880 25.3% Phase 3- validated, ramping into profitable growth
    20 20 TNY [TINY BEANS]   23/4/19   $   0.605   $    1.230 103.3% Phase 2-3- validated & ramping & getting into profitability
    21 21 MVP [MEDICAL DEV ITNL]   26/4/19   $   5.450   $    6.100 11.9% Phase 3-4-growth
    22 22 STG [STRAKER TRANSLATIONS]   29/4/19   $   1.580   $    1.960 24.1% Phase 2-3- validated & ramping & getting into profitability
    23 23 PPS [PRAEMIUM]   21/5/19   $   0.400   $    0.470 17.5% Re-rating opportunity from an oversold position
    24 24 NXS [NEXT SCIENCE]   22/5/19   $   2.400   $    3.810 58.8% Phase 2- validated & just started growth phase [significant potential]
    25 25 BLACK CAT SYND [BC8]   22/5/19   $   0.295   $    0.330 11.9% Phase 1- positive discovery
    26 26 I SIGN THIS [ISX]   27/5/19   $   0.645   $    0.670 3.9% Phase 2-3- validated & ramping & getting into profitability
    27 27 PROTEOMICS [PIQ]   4/6/19   $   0.275   $    0.330 20.0% Phase 1- positive validated IP , awaiting business development catalyst for a substantial re-rate
    28 28 ANO [ADVANCED NANOTEK]   12/6/19   $ 6.09   $    4.720 -22.5% Phase 4-growth
    29 29 CLV [CLOVER]   13/6/19   $   1.875   $    2.080 10.9% Phase 4- growth
    30 30 AMS [ATOMOS]   1/7/19   $   1.080   $    1.380 27.8% Phase 3- growth, ebitda positive high growth high margin business
    31 31 OEC [ORBITAL CORP]   4/7/19   $   0.350   $    0.325 -7.1% Undervalued $25m company that has secured a min $120m 5 year contract with Boeing subsidiary
    32   LOTTERY STOCKS          
    33 32 4DS [4DS] [closed]   20/2/19   $   0.067   $    0.076 13.4% Phase 1-positive discovery
    34 33 BIT [BIOTRON]   20/2/19   $   0.090   $    0.084 -6.7% Phase 1-positive discovery
    35 34 ACW [ACTINOGEN] [closed]   20/2/19   $   0.054   $    0.014 -74.1% Failed to demonstrate cognitive improvement
    36 35 LOM [LUCAPA DIAMOND]   31/5/19   $   0.150   $    0.160 6.7% Undervalued and a spec punt for Lulo mother load find
    37   COMPOSITE RETURN%       16.8%  
    38   SMALL CAP ORDS RETURN% SINCE 11/2/19       8.1%  
    39   SUPPLEMENTARY STOCK          
    40 S-1 AER [AERRIS]   2/5/19   $   0.100   $    0.140 40.0% Phase 2- $6m penny stock / validated
    41 S-2 LBT [LBT INNOVATIONS]   28/6/19   $   0.120   $    0.120 0.0% Product FDA validated $28m market cap
    42 S-3 UUV [AQUABOTIX]   3/7/19   $   0.008   $    0.007 -12.5% US Defence endorsed Swarm robotic drone IP tech for <$3m!
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.